Guangzhou Continent Biomedical Technology

Guangzhou Continent Biomedical Technology Co., Ltd. is a biopharmaceutical company based in Guangzhou, China, specializing in the development and commercialization of transdermal drug delivery systems (TDDS) and innovative small molecule therapeutics. The company is recognized as a significant player in the global transdermal preparation market, offering non-invasive delivery solutions for chronic conditions such as pain management and cardiovascular diseases. Its research and development pipeline includes discovery-stage small molecule GLP-1 receptor agonists aimed at treating endocrinology and metabolic disorders. Additionally, the company is involved in the production of heparin sodium and other anticoagulant treatments. Guangzhou Continent leverages advanced material science and formulation technologies to ensure steady-state drug release and improved patient compliance.